Related Experiment Videos
Hepatitis B surface antigen in hepatocytes at necropsy
Archives of Pathology & Laboratory Medicine
|May 1, 1980
Summary
Gomori's aldehyde fuchsin stain reliably detects hepatitis B surface antigen (HBsAg) in liver tissue. This method strongly correlates with serum HBsAg levels in patients with cirrhosis, hepatocellular carcinoma, or no primary liver disease.
Area of Science:
- Hepatology
- Virology
- Pathology
Background:
- Hepatitis B virus (HBV) infection is a major cause of chronic liver disease, cirrhosis, and hepatocellular carcinoma (HCC).
- Accurate detection of hepatitis B surface antigen (HBsAg) in liver tissue is crucial for diagnosis and prognosis.
- Previous methods for HBsAg detection in tissue have limitations.
Purpose of the Study:
- To evaluate the reliability of Gomori's aldehyde fuchsin stain for detecting HBsAg in liver cells.
- To correlate tissue-based HBsAg detection with serum HBsAg levels.
Main Methods:
- Investigated 70 cases of cirrhosis and HCC, and 43 controls without primary liver disease.
- Utilized Gomori's aldehyde fuchsin stain on liver tissue obtained at necropsy.
- Correlated tissue findings with serum HBsAg levels determined by radioimmunoassay and hemagglutination tests.
Main Results:
- Gomori's aldehyde fuchsin stain demonstrated HBsAg in liver cells in a high percentage of cases.
- Over 90% correlation was observed between HBsAg detection in liver tissue and serum levels.
- The stain proved effective across patient groups, including those with cirrhosis, HCC, and no primary liver disease.
Conclusions:
- Gomori's aldehyde fuchsin stain is a reliable diagnostic tool for detecting HBsAg in liver tissue.
- This staining method provides results that correlate well with serological tests for HBsAg.
- The stain is valuable for diagnosing HBV-related liver conditions, including cirrhosis and HCC.